These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

A new year means new laws that have gone into effect here in Illinois. Governor J.B. Pritzker said that "For thousands of Illinoisans, the reforms in this bill will mean the difference between ...

A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell ca ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Jammu, took a significant step in cancer management by unveiling the Cancer Policy for Jammu and Kashmir on Tuesday.

Advanced prostate cancer cases in California are rising faster than the national average, according to a UCSF study. Experts urge smarter screening to catch aggressive cases early.